Zacks Investment Management Assembly Biosciences, Inc. Transaction History

Zacks Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $182,071 - $274,496	-18,522 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $141,900 - $228,800	-11,000 Reduced 37.26%	18,522 $250,000
Q1 2019 May 15, 2019	BUY	$17.7 - $24.93 $522,539 - $735,983	29,522 New	29,522 $581,000
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $1.4 Million - $1.8 Million	-35,724 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$41.7 - $64.16 $1.51 Million - $2.33 Million	-36,238 Reduced 50.36%	35,724 $1.76 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $2.06 Million - $3.59 Million	71,962	71,962 $3.26 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $782M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.